Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases
Learn more about:
Related Clinical Trial
COVID-19 Vaccine Responses in PIDD Subjects
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases